Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Opinion in Endocrinology, Diabetes and Obesity is Scopus-indexed (Q1, CiteScore 6.2), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Lippincott Williams and Wilkins.
Checked against the index lists dated .
ISSN 1752-296XVerify ISSN ↗1752-2978Verify ISSN ↗
Publisher: Lippincott Williams and Wilkins
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Internal Medicine | 45 / 179 | 75th | Q1 |
| Nutrition and Dietetics | 43 / 147 | 71st | Q2 |
| Endocrinology, Diabetes and Metabolism | 76 / 250 | 69th | Q2 |
| Endocrinology | 47 / 132 | 64th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2007–present, best quartile Q1, CiteScore 6.2.
Current Opinion in Endocrinology, Diabetes and Obesity is Q1 in Internal Medicine (rank 45 of 179), Q2 in Nutrition and Dietetics (rank 43 of 147) and Q2 in Endocrinology, Diabetes and Metabolism (rank 76 of 250), by CiteScore 2025. It is ranked in 4 subject areas in all.
Current Opinion in Endocrinology, Diabetes and Obesity is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.2, which places it in quartile Q1 at the 75th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.984, quartile Q1, with an H-index of 93.
Current Opinion in Endocrinology, Diabetes and Obesity is published by Lippincott Williams and Wilkins. Its print ISSN is 1752-296X and its online ISSN is 1752-2978.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Current Opinion in Endocrinology, Diabetes and Obesity has an h-index of 102 and a 2-year mean of 3.4 citations per paper (OpenAlex). Its Scopus CiteScore is 6.2, quartile Q1. On 2-year citations it ranks #41 of 172 Scopus journals in Internal Medicine.
Current Opinion in Endocrinology, Diabetes and Obesity published 45 papers in 2025; its busiest recent year was 2021 with 86. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2023–2026), authors are most often from United States (26%), Australia (22%) and India (11.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.